Minocycline in rheumatoid arthritis rationale and trial results

Clinical Immunotherapeutics

Volumn 5, Issue 1, 1996, Pages 1-4

  Kloppenburg, Margreet ^a   Breedveld, Ferdinand C ^a   Dijkmans, Ben A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; MINOCYCLINE; TETRACYCLINE DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; IMMUNOMODULATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030058337     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259310     Document Type: Article

References (39)

1. Golub LM, Lee HM, Lehrer G, et al. Minocycline reduces gingival collagenolytic activity during diabetes. J Periodont Res 1983; 18:516-24
2. Golub LM. Ramamurthy NS, McCamara TF. et al. Tetracyclines inhibit tissue collagenase activity. J Periodont Res 1984: 19: 651-5
3. Golub LM, Wolff M, Lee HM. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodont Res 1985; 20: 12-3
4. Greenwald RA, Golub LM, Lavietes B, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987; 14; 28-32
5. Gomes BC, Golub LM, Ramamurthy NS. Tetracyclines inhibit parathyroid hormone induced bone résorption in organ culture. Experientia 1984; 40: 1273-5
6. Seedor JA, Perry HD, Buxton DF. Systemic tetracycline in the treatment of alkali induced corneal ulcération in the rabbit. Invest Ophthalmol Vis Sei 1985; 26: 319-24
7. Lauhio A, Sorga T, Lindy O, et al. The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. Arthritis Rheum 1992; 35: 195-8
8. Breedveld FC, Trentham DE. Suppression of collagen and adjuvant arthritis by a tetracycline. Arthritis Rheum 1988; 31 Suppl.: R9
9. Greenwald RA, Moak SA, Ramamurthy NS, et al. Tetracyclin suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992; 19: 927-38
10. Yu Jr.LP, Smith Jr.GN, Brandt RD, et al. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992; 35: 1150-9
11. Humbert P, Treffe! P, Chapuis JF, et al. The tetracyclines in dermatology. J Am Acad Dermatol 1991 ; 25: 691-7
12. Martin RR, Warr GA, Couch RB, et al. Effects of tetracycline on leucotaxis. J Infect Dis 1974; 129: 110-6
13. Forsgren A, Schmeling D, Quic PG. Effect of tetracycline on the phagocytic function of human leucocytes. J Infect Dis 1974; 130:412-5
14. Gabler WL, Creamer HR. Suppression of human neutrophil function by tetracyclines. J Periodont Res 1991; 26: 52-8
15. Miyachi Y, Yoshidia A, Imamura S, et al. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 1986; 86: 449-53
16. Thong IH, Ferrante A. Inhibition of mitogen induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol 1979; 443-6
17. Ingham E, Turnbull L, Kearney JN, et al. The effects of minocycline and tetracycline on the mitotic response of human peripheral blood lymphocytes. J Antimicrob Chemotherapy 1991; 27: 607-17
18. Thon IH, Ferrante A. Effect of tetracycline treatment on immunological responses in mice. Clin Exp Immunol 1980; 39: 728-32
19. Bogert van den C, Kroon AM. Effects of oxytetracycline on in vivo proliferation and differentiation of erythroid and lymphoid cells in the rat. Clin Exp Immunol 1982; 50: 327-35
20. Brown TM, Bush SW, Felts WR. Long-term illness: management of the chronically ill patient. In: Wohe MG, editor. Philadelphia: W.B. Saunders, 1959; 93-125
21. Skinner M, Cathart S, Mills JA, et al. Tetracycline in the treatment of rheumatoid arthritis. A double blind controlled study. Arthritis Rheum 1971; 14: 727-32
22. Beard Jr.NS, Armentnout SA, Weisberger AS. Inhibition of mammalian protein synthesis by antibiotics. Pharmacol Rev 1969; 21:213-45
23. De Jonge HR. Toxicity of tetracyclines in rat-small-intestinal epithelium and liver. Biochem Pharmacol 1973; 22: 2659-77
24. Riesbeck K, Bredberg A, Forsgren A. Ciproflaxin does not inhibit mitochondrial function but other antibiotics do. Antimicrob Agents Chemother 1990; 34: 167-9
25. Athlin L, Domellof L, Norberg B. The effect of an oral therapeutic single dose of doxycycline on subsequent monocyte phagocytosis in vitro. Acta Chir Scand 1986; 152: 9-13
26. Bogert van den C, Melis TE, Kroon AM. Mitochondrial biogenesis during the activation of lymphocytes by mitogens: the immunosuppressive action of tetracyclines. J Leukoc Biol 1989;46: 128-35
27. Lee HM, Golub LM, Gwinnett AJ, et al. Minocycline inhibits collagenase and elastase produced by rat macrophages in cell culture. J Dent Spec Issue 1985; 64: 305
28. Sasaki T, Ramamurthy NS, Golub LM. Tetracycline administration increases collagen synthesis in osteoblasts of streptozocin-induced diabetic rats: a quantitative audioradiographic study. Calcif Tissue Int 1992; 50: 411-9
29. Chowdhury ANH, Moak SA, Rifkin BR, et al. Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone résorption by chick osteoblasts. Agents Actions 1993; 40: 124-9
30. Golub LM, Ramamurthy NS, Kaneko H, et al. Tetracycline administration prevents diabetes-induced osteopenia in the rat: initial observations. Res Commun Chem Pathol Pharmacol 1990; 68: 27-40
31. Pott HG, Wittenburg A, Hulsing-Jonge G. Long-term antibiotic treatment in reactive arthritis. Lancet 1988; i: 245-6
32. Panayi GS, Clark B. Minocycline in the treatment of patients with Reiter's syndrome. Clin Exp Immunol 1989; 39: 728-32
33. Lauhio A, Leirisalo-Repo M, Lähdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34: 6-14
34. Fryden A, Bengtsson A, Foberg U, et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ 1990; 301: 1299-302
35. Breedveld FC, Dijkmans BAC, Mattie H. Minocycline treatment for rheumatoid arthritis: an open dose finding study. JRheumatol 1990; 17:43-6
36. Langevitz P, Bank 1, Zemer D, et al. Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol 1992; 19: 1502-4
37. Kloppenburg M, Breedveld FC, Terwiel JP, et al. Minocycline in active rheumatoid arthritis: a double-blind, placebo controlled trial. Arthritis Rheum 1994; 37: 629-36
38. Tilley BC, Alarcon GS, Heupe SP, et al. Minocycline in rheumatoid arthritis: a 48-week double blind, placebo-controlled trial. Ann Intern Med 1995; 122: 81-9
39. Paulus HE. Minocycline treatment of rheumatoid arthritis. Ann Intern Med 1995; 122: 147-8